Collection: Hifas da Terra

A TRUE STORY OF INNOVATION

Hifas da Terra has more than 15 active clinical studies evaluating the health benefits of supplementation with its products, including two oncological clinical trials in patients with colorectal cancer (Micromarker project), breast cancer (Microimmunomama project), two highly innovative clinical trials in the area of women’s health and clinical studies in patients with SIBO in Irritable Bowel Syndrome, DAO deficiency and diverticular disease, among others.

With a large multidisciplinary and mostly female scientific team – made up of professionals in biology, pharmacy, medicine and oncology, etc. – Hifas da Terra collaborates with national and international research centres to develop R&D&I projects and clinical trials, mainly in the areas of gastro-intestinal, immunology, oncology, musculoskeletal and mental-emotional health.

Controls on safety, purity, determination of concentration of active biomolecules and confirmation of the stability of the final product. This includes microbiological, pesticide, heavy metals and gluten testing.

Extract fingerprint: extract fingerprints are obtained using advanced analytical techniques, and enable us to substantiate the identity of the extract

Mayte Monreal Núñez / HI Hub Clinical Operations Manager

Our commitment to quality and traceability is strong and unique:

Our Mico-Quality production process includes up to 3 rounds of analytical control of both raw materials and final products to ensure maximum safety and effectiveness.

Maximum concentration via a dual extraction process: Dual extraction, an exclusive patent-pending process, allows us to more efficiently and sustainably obtain standardised levels of active biomolecules in our medicinal mushrooms at higher concentrations than those offered by other natural products.